Orion Pharma Limited (DSE:ORIONPHARM)

Orion Pharma Statistics

Total Valuation

Orion Pharma has a market cap or net worth of BDT 6.69 billion. The enterprise value is 34.20 billion.

Market Cap	6.69B
Enterprise Value	34.20B

Important Dates

The last earnings date was Tuesday, November 11, 2025.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	Dec 5, 2024

Share Statistics

Orion Pharma has 234.00 million shares outstanding.

Current Share Class	234.00M
Shares Outstanding	234.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.07
PB Ratio	0.30
P/TBV Ratio	0.32
P/FCF Ratio	8.53
P/OCF Ratio	8.14
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 66.32, with an EV/FCF ratio of 43.59.

EV / Earnings	-63.28
EV / Sales	10.59
EV / EBITDA	66.32
EV / EBIT	n/a
EV / FCF	43.59

Financial Position

The company has a current ratio of 2.08, with a Debt / Equity ratio of 1.16.

Current Ratio	2.08
Quick Ratio	1.79
Debt / Equity	1.16
Debt / EBITDA	51.52
Debt / FCF	33.36
Interest Coverage	-0.12

Financial Efficiency

Return on equity (ROE) is -2.76% and return on invested capital (ROIC) is -0.07%.

Return on Equity (ROE)	-2.76%
Return on Assets (ROA)	-0.06%
Return on Invested Capital (ROIC)	-0.07%
Return on Capital Employed (ROCE)	-0.11%
Revenue Per Employee	1.09M
Profits Per Employee	-182,936
Employee Count	2,954
Asset Turnover	0.06
Inventory Turnover	1.18

Taxes

In the past 12 months, Orion Pharma has paid 104.49 million in taxes.

Income Tax	104.49M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.32% in the last 52 weeks. The beta is -0.58, so Orion Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.58
52-Week Price Change	-28.32%
50-Day Moving Average	31.09
200-Day Moving Average	31.22
Relative Strength Index (RSI)	46.39
Average Volume (20 Days)	263,163

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orion Pharma had revenue of BDT 3.23 billion and -540.39 million in losses. Loss per share was -2.31.

Revenue	3.23B
Gross Profit	1.26B
Operating Income	-53.71M
Pretax Income	-516.53M
Net Income	-540.39M
EBITDA	490.94M
EBIT	-53.71M
Loss Per Share	-2.31

Balance Sheet

The company has 106.12 million in cash and 26.17 billion in debt, giving a net cash position of -26.05 billion or -111.32 per share.

Cash & Cash Equivalents	106.12M
Total Debt	26.17B
Net Cash	-26.05B
Net Cash Per Share	-111.32
Equity (Book Value)	22.49B
Book Value Per Share	89.86
Working Capital	9.07B

Cash Flow

In the last 12 months, operating cash flow was 822.18 million and capital expenditures -37.69 million, giving a free cash flow of 784.49 million.

Operating Cash Flow	822.18M
Capital Expenditures	-37.69M
Free Cash Flow	784.49M
FCF Per Share	3.35

Margins

Gross margin is 39.06%, with operating and profit margins of -1.66% and -16.73%.

Gross Margin	39.06%
Operating Margin	-1.66%
Pretax Margin	-15.99%
Profit Margin	-16.73%
EBITDA Margin	15.20%
EBIT Margin	-1.66%
FCF Margin	24.29%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 3.50%.

Dividend Per Share	1.00
Dividend Yield	3.50%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	3.57%
Earnings Yield	-8.07%
FCF Yield	11.72%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 27, 2013. It was a forward split with a ratio of 1.2.

Last Split Date	May 27, 2013
Split Type	Forward
Split Ratio	1.2

Scores

Orion Pharma has an Altman Z-Score of 0.55 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.55
Piotroski F-Score	4